Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine with High-Dose Chemotherapy and Stem Cell Transplant for Multiple Myeloma
NCT00003401Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 1999
- Primary completion
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in multiple myeloma (MM), sponsored by University of Maryland, Baltimore. Started Jan 1999; status: completed.
02
Drugs
gemcitabine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003401.